NCT06069570 2025-03-05
Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases
Kiromic BioPharma Inc.
Phase 1 Recruiting
Kiromic BioPharma Inc.
H. Lee Moffitt Cancer Center and Research Institute